» Articles » PMID: 33733500

Bayesian Design and Analysis of External Pilot Trials for Complex Interventions

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2021 Mar 18
PMID 33733500
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

External pilot trials of complex interventions are used to help determine if and how a confirmatory trial should be undertaken, providing estimates of parameters such as recruitment, retention, and adherence rates. The decision to progress to the confirmatory trial is typically made by comparing these estimates to pre-specified thresholds known as progression criteria, although the statistical properties of such decision rules are rarely assessed. Such assessment is complicated by several methodological challenges, including the simultaneous evaluation of multiple endpoints, complex multi-level models, small sample sizes, and uncertainty in nuisance parameters. In response to these challenges, we describe a Bayesian approach to the design and analysis of external pilot trials. We show how progression decisions can be made by minimizing the expected value of a loss function, defined over the whole parameter space to allow for preferences and trade-offs between multiple parameters to be articulated and used in the decision-making process. The assessment of preferences is kept feasible by using a piecewise constant parametrization of the loss function, the parameters of which are chosen at the design stage to lead to desirable operating characteristics. We describe a flexible, yet computationally intensive, nested Monte Carlo algorithm for estimating operating characteristics. The method is used to revisit the design of an external pilot trial of a complex intervention designed to increase the physical activity of care home residents.

Citing Articles

Three-outcome designs for external pilot trials with progression criteria.

Wilson D, Hudson E, Brown S BMC Med Res Methodol. 2024; 24(1):226.

PMID: 39358754 PMC: 11446087. DOI: 10.1186/s12874-024-02351-x.


Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.

Lee S BMC Med Res Methodol. 2024; 24(1):110.

PMID: 38714936 PMC: 11077897. DOI: 10.1186/s12874-024-02235-0.

References
1.
Teare M, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters S . Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014; 15:264. PMC: 4227298. DOI: 10.1186/1745-6215-15-264. View

2.
Avery K, Williamson P, Gamble C, OConnell Francischetto E, Metcalfe C, Davidson P . Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017; 7(2):e013537. PMC: 5318608. DOI: 10.1136/bmjopen-2016-013537. View

3.
Browne R . On the use of a pilot sample for sample size determination. Stat Med. 1995; 14(17):1933-40. DOI: 10.1002/sim.4780141709. View

4.
Mander A, Wason J, Sweeting M, Thompson S . Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis. Pharm Stat. 2012; 11(2):91-6. DOI: 10.1002/pst.501. View

5.
Dallow N, Best N, Montague T . Better decision making in drug development through adoption of formal prior elicitation. Pharm Stat. 2018; 17(4):301-316. DOI: 10.1002/pst.1854. View